Skip to content

Characteristics of medications for the treatment of lower urinary tract symptoms after midurethral sling in women

Characteristics of medications for the treatment of lower urinary tract symptoms after midurethral sling in women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005821
Enrollment
373716
Registered
2021-01-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University, Wonju Severance Christian Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women with stress urinary incontinence and received midurethral sling

Exclusion criteria

Exclusion criteria: men

Design outcomes

Primary

MeasureTime frame
Treatment with urologic medication or not

Secondary

MeasureTime frame
Recurrence of stress urinary incontinence

Countries

Korea, Republic of

Contacts

Public ContactSu Jin Kim

Yonsei University, Wonju Severance Christian Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026